Feinstein Institute Presents Inaugural Ross Prize to NYU Researcher

New York, NY – The Feinstein Institute for Medical Research Monday presented the first annual Ross Prize in Molecular Medicine to New York University (NYU) immunology researcher Dan R. Littman, MD, PhD for his early discoveries and ongoing research to better understand viral, immune and inflammatory diseases. This was the first conferred Ross Prize, an annual award, which includes a $50,000 prize, by the peer-reviewed, open-access journal Molecular Medicine.

“The Ross Prize in Molecular Medicine was conceived to recognize scientific advances and to honor people whose discoveries change the way medicine is practiced,” said Kevin J. Tracey, MD, president of the Feinstein Institute, editor-in-chief of Molecular Medicine, and Ross Prize committee member.

“Dr. Litman’s contributions to the fields of immunology and virology are impressive and justly recognized today,” Michael J. Dowling, president and chief executive officer of the North Shore-LIJ Health System, said at the award presentation held Monday at the New York Academy of Sciences in Manhattan.

Dr. Littman is the Helen L. and Martin S. Kimmel Professor of Molecular Immunology in the Skirball Institute of Biomolecular Medicine at NYU School of Medicine. He is a Howard Hughes Medical Institute investigator, and a member of both the National Academy of Sciences and the Institute of Medicine.

During the event at the New York Academy of Sciences, the award was presented to Dr. Littman by Betty Diamond, MD, head, Center for Autoimmune Diseases and Musculoskeletal Disorders at the Feinstein Institute. After the award presentation, Dr. Littman and Yasmine Belkaid, PhD, National Institute of Allergy and Infectious Diseases, NIH, and Alexander Rudensky, PhD, Memorial Sloan-Kettering Cancer Center each presented scientific lectures.

The Ross Prize is awarded annually by Molecular Medicine to mid-career scientists who have made a demonstrable impact in the understanding of human diseases pathogenesis and/or treatment, and who hold significant promise for making even greater contributions to the general field of molecular medicine. The Feinstein Institute announced in February that Dr. Littman is the recipient of the inaugural prize.

The Ross Prize in Molecular Medicine was made possible by the generosity of Feinstein Institute board members Robin and Jack Ross of Upper Brookville, NY.

About Molecular Medicine

Molecular Medicine is an open access, international, peer-reviewed biomedical journal published by The Feinstein Institute for Medical Research. Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. To learn more, visit www.molmed.org.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in Parkinson’s disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information visit www.FeinsteinInstitute.org.

Media Contact:
Emily Ng